Brief: Promore Pharma Regains Rights For Pxl01 Manufacturing
Feb 15 (Reuters) - PROMORE PHARMA AB PROMO.ST :
* PROMORE PHARMA REGAINS RIGHTS FOR PXL01 MANUFACTURING
* WILL ASSUME RESPONSIBILITY FOR MANUFACTURING OF
INVESTIGATIONAL
MEDICINAL PRODUCT FOR CLINICAL PHASE III TRIAL FOR PXL01
Source text for Eikon: ID:nWkr4lKPnB
Further company coverage: PROMO.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on PMD Device Solutions AB
See all newsBrief: PMD Device Solutions Files For Bankruptcy
Brief: PMD Device Solutions Q3 EBITDA Loss Widens To SEK 8.9 Mln
Brief: Pmd Device Solutions Completes Sale Of Coala Life Monitor
Brief: PMDS’ Largest Shareholder Requests EGM To Appoint New Non-Executive Directors
Brief: PMDS Says RespiraSense Technology Demonstrates Capability In Predicting 7-Day Mortality